Monitoring
HE4 is a secreted protein that is over expressed and can be detected in high levels in women with ovarian cancer. It is cleared by the FDA for use to monitor recurrence or progressive disease in patients with epithelial ovarian cancer.
Monitor Ovarian Cancer using HE4
- HE4 increases by 25% or greater in 60% of patients with disease3
- HE4 remains constant in 75% of patients without progression of disease3
Click to find out how to order the HE4 blood test.
If you are interested in performing the HE4 test in your laboratory please contact us at: info@fdi.com.
